Immunomedics Earnings: Your Sneak Peek to the Big Announcement

Immunomedics (NASDAQ:IMMU) will report earnings after markets close on Wednesday, May 8th. Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company’s products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.

Here is your Cheat Sheet to Immunomedics Earnings:

Earnings Expectations: Analysts expect earnings of $-0.10 per share on revenues of $970.00K.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.07 to a loss $0.1. For the current year, the average estimate is a loss of $0.39, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Immunomedics has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 3.65 30.02 60.93 14.71 32.73
Diluted EPS ($) -0.31 0.03 0.49 -0.20 0.01

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 29.66 0.97 0.96 1.05 0.81
Diluted EPS ($) 0.27 -0.10 -0.0995 -0.10 -0.07

Past Performance:
Immunomedics has beat analyst estimates 1 time in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]